The Effect of Eprosartan in Patients With Essential Hypertension on Renal Tubular Function and Vasoactive Hormones During Baseline Conditions and After Activation of the Sympathetic Nervous System.
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2010
At a glance
- Drugs Eprosartan (Primary)
- Indications Essential hypertension
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Oct 2010 Status changed from active, no longer recruiting to completed.
- 26 Sep 2010 Primary endpoint 'Noradrenaline levels' has not been met.